Memorial Sloan Kettering hematologic oncologist Kamal Menghrajani

Kamal Menghrajani, MD

Leukemia Specialist

Titles

Assistant Attending Physician

Clinical Expertise

Leukemia; Myeloproliferative Neoplasms; Myelodysplastic Syndrome

Back to top
Share

Contact and Location

Locations map
Find a Convenient Location

Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offer many services, including screening, chemotherapy, and medical testing.

See all locations

About Me

Education

MD, University of North Carolina at Chapel Hill

Residencies

Internal Medicine - University of Michigan

Fellowships

Medical Oncology, Hematology - Memorial Sloan Kettering Cancer Center

Board Certifications

Internal Medicine; Hematology; Medical Oncology

In every patient interaction, I want patients and their families to feel heard.

-Dr. Menghrajani

Awards and Honors

  • American Society of Clinical Oncology Young Investigator Award
  • National Institutes of Health K12 / Paul Calabresi Career Development Award for Clinical Oncology
  • Chief Fellow, Hematology, Memorial Sloan Kettering Cancer Center

Colleagues

Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.

See all Leukemia Service doctors

Clinical Trials

Smiling doctors in the lab
Find a Clinical Trial for You

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.

You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.

Search clinical trials

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Kamal Menghrajani discloses the following relationships and financial interests:

No disclosures meeting criteria for time period


If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.

The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.

This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].


View all disclosures

Related topics: